miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer
Open Access
- 7 September 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , srep32541
Abstract
Dysregulation of PI3K and MAPK pathways promotes uncontrolled cell proliferation, apoptotic inhibition and metastasis. Individual targeting of these pathways using kinase inhibitors has largely been insufficient due to the existence of cross-talks between these parallel cascades. MicroRNAs are small non-coding RNAs targeting several genes simultaneously and controlling cancer-related processes. To identify miRNAs repressing both PI3K and MAPK pathways in breast cancer, we re-analyzed our previous miRNA mimic screen data with reverse phase protein array (RPPA) output and identified miR-564 inhibiting both PI3K and MAPK pathways causing markedly decreased cell proliferation through G1 arrest. Moreover, ectopic expression of miR-564 blocks epithelial-mesenchymal transition (EMT) and reduces migration and invasion of aggressive breast cancer cells. Mechanistically, miR-564 directly targets a network of genes comprising AKT2, GNA12, GYS1 and SRF, thereby facilitating simultaneous repression of PI3K and MAPK pathways. Notably, combinatorial knockdown of these target genes using a cocktail of siRNAs mimics the phenotypes exerted upon miR-564 expression. Importantly, high miR-564 expression or low expression of target genes in combination is significantly correlated with better distant relapse-free survival of patients. Overall, miR-564 is a potential dual inhibitor of PI3K and MAPK pathways and may be an attractive target and prognostic marker for breast cancer.Keywords
This publication has 86 references indexed in Scilit:
- miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumoursEMBO Molecular Medicine, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The microcosmos of cancerNature, 2012
- Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancerMolecular Systems Biology, 2012
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- The role of site accessibility in microRNA target recognitionNature Genetics, 2007
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The Hallmarks of CancerCell, 2000